NS · Healthcare

Vilin Bio Med Ltd (VILINBIO)

Pharmaceuticals & Biotechnology

Vilin Bio Med Ltd (VILINBIO) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $702.30M, P/E ratio is 39.21. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for VILINBIO

Market cap

$702.30M

P/E ratio

39.21

Vilin Bio Med Ltd (VILINBIO) — FAQ

What is Vilin Bio Med Ltd's market cap?

Vilin Bio Med Ltd (VILINBIO) has a reported market cap of $702.30M (data as of 2026-07-10).

What is VILINBIO's P/E ratio?

The price-to-earnings (P/E) ratio for Vilin Bio Med Ltd (VILINBIO) is 39.21 (data as of 2026-07-10).

Does Vilin Bio Med Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Vilin Bio Med Ltd (VILINBIO). Check the MyAverix Finance app for the latest dividend data.

What sector is Vilin Bio Med Ltd in?

Vilin Bio Med Ltd (VILINBIO) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).

What exchange is VILINBIO listed on?

VILINBIO is listed on NS.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

09R (09R) 10X GENOMICS DL -00001 (1KJ) 160 Health International Ltd (2656) 1CM INC. (IQ70) 2cureX AB (2CUREX) 3-D Matrix Ltd (DMTRF) 3D Global Biotech Inc. (6808) 3D Medicines Inc (1244)